CCO Expert Recap

Update on Investigational Agents in HCV: 2007

Source: 2007 Annual Meeting of the American Association for the Study of Liver Diseases*

*CCO is an independent medical education company that provides state-of-the-art medical information to healthcare professionals through conference coverage and other educational programs.

Update on Investigational Agents in HCV: 2007

Faculty:

Ira M. Jacobson, MD headshot
  • Ira M. Jacobson, MD

CME CREDIT INFORMATION

Release Date: 01/07/08

Expiration Date: 01/06/09


Physicians: maximum of 0.75 AMA PRA Category 1 Credit(s)™

Status: Please log in to view status


Watch and listen as Ira M. Jacobson, MD, reviews key data on investigational HCV agents presented at the 2007 Boston liver disease meeting.

Learning Objectives

Upon completion of this activity, participants should be able to:

  • Discuss emerging efficacy and safety data on small-molecule specifically targeted anti-HCV agents
  • Describe the current understanding of resistance mutations with investigational agents
  • Summarize data on novel immunomodulatory agents with anti-HCV activity

Slideset

Update on Investigational Agents in HCV: 2007


Review the most clinically relevant data on HCV investigational agents from the 2007 Boston meeting and download the slides for use in your own presentations.


Format: Microsoft PowerPoint (.ppt) | File size: 427 KB

Jointly sponsored by Postgraduate Institute for Medicine and Clinical Care Options, LLC.

Educational grant provided by:

Educational grants support only the CME-certified components of this program.